iBio IBIO
NASDAQ IBIO
$1.43 -0.04 (-2.72%)
At close: Aug 21, 2026 · 4:00 PM EDT

iBio (IBIO) Capital Leases (2016 - 2024)

iBio (IBIO) posted quarterly Capital Leases of $53000.0 for Q2 2024, down 84.9% year-over-year from $351000.0 in Q3 2023, and down 59.23% quarter-over-quarter from $130000.0 in Q1 2024.

iBio (IBIO) Capital Leases (2016 - 2024) Analysis & Trends

iBio (IBIO) has reported Capital Leases for 9 consecutive years, with $53000.0 the latest figure, recorded in Q2 2024.

  • In Q2 2024, Capital Leases fell 84.9% year-over-year to $53000.0; the TTM figure through Jun 2024 stood at $53000.0 (down 84.9% YoY), while the FY2024 annual figure was $53000.0, down 84.9% from the prior year.
  • Capital Leases retreated to $53000.0 in Q2 2024 per IBIO's latest filing, from $130000.0 in the prior quarter.
  • Across five years, Capital Leases topped out at $32.1 million in Q1 2020 and bottomed at $30000.0 in Q2 2022.
  • Historically, Capital Leases has averaged $12.5 million across 5 years, with a median of $456000.0 in 2022.
  • Annual changes were most pronounced in 2022 — Capital Leases plunged 99.91% — and 2023, when it soared 1070.0%.
  • iBio's Capital Leases stood at $31.8 million in 2020, then tumbled by 99.84% to $51000.0 in 2021, then jumped by 860.78% to $490000.0 in 2022, then sank by 58.16% to $205000.0 in 2023, then tumbled by 74.15% to $53000.0 in 2024.
  • Business Quant data shows IBIO's Capital Leases at $53000.0 in Q2 2024, $130000.0 in Q1 2024, and $205000.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 iBio 172.22 Mn 172.22 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2024 53,000.00
Mar 31, 2024 130,000.00
Dec 31, 2023 205,000.00
Sep 30, 2023 53,000.00
Jun 30, 2023 351,000.00
Mar 31, 2023 422,000.00
Dec 31, 2022 490,000.00
Sep 30, 2022 576,000.00
Jun 30, 2022 30,000.00
Mar 31, 2022 41,000.00
Dec 31, 2021 51,000.00
Sep 30, 2021 31.66 Mn
Jun 30, 2021 31.76 Mn
Mar 31, 2021 31.77 Mn
Dec 31, 2020 31.85 Mn
Sep 30, 2020 31.93 Mn
Jun 30, 2020 32.01 Mn
Mar 31, 2020 32.08 Mn
Mar 31, 2019 24.73 Mn
Dec 31, 2018 24.78 Mn